ArticleBMC complementary and alternative medicine2017

Safety of intravenously applied mistletoe extract - results from a phase I dose escalation study in patients with advanced cancer.

Roman Huber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.